Phosphatidylinositol 3-kinase in breast cancer (vol 13, pg 5988, 2007)

被引：0
|
作者：
不详
机构：
来源：
CLINICAL CANCER RESEARCH | 2008年 / 14卷 / 04期
关键词：
D O I：
10.1158/1078-0432.CCR-14-4-COR
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1281 / 1281
页数：1
相关论文
共 50 条
  • [21] Phosphatidylinositol 3-kinase in myogenesis
    Kaliman, P
    Zorzano, A
    TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (06) : 198 - 202
  • [22] Vps34 is a phosphatidylinositol 3-kinase, not a phosphoinositide 3-kinase
    Meijer, Alfred J.
    Klionsky, Daniel J.
    AUTOPHAGY, 2011, 7 (06) : 563 - 564
  • [23] Phosphatidylinositol 3-Kinase (PI3K) Pathway Activation in Breast Cancer Brain Metastases
    Anders, C. K.
    Adamo, B.
    Deal, A. M.
    Livasy, C. A.
    Meng, H.
    Burrows, E.
    Fritchie, K.
    Blackwell, K. L.
    Geradts, J.
    Ewend, M. G.
    Carey, L. A.
    Miller, R.
    CANCER RESEARCH, 2010, 70
  • [24] A Rap/Phosphatidylinositol 3-Kinase Pathway Controls Pseudopod Formation (vol 21, pg 936, 2010)
    Kortholt, A.
    Bolourani, P.
    Rehmann, H.
    Keizer-Gunnink, I.
    Weeks, G.
    Wittinghofer, A.
    Van Haastert, P. J. M.
    MOLECULAR BIOLOGY OF THE CELL, 2010, 21 (07) : 1314 - 1314
  • [25] Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
    Miller, Todd W.
    Rexer, Brent N.
    Garrett, Joan T.
    Arteaga, Carlos L.
    BREAST CANCER RESEARCH, 2011, 13 (06)
  • [26] Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancer
    Parsons, R
    CLINICAL CANCER RESEARCH, 2005, 11 (22) : 7965 - 7966
  • [27] Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
    Todd W Miller
    Brent N Rexer
    Joan T Garrett
    Carlos L Arteaga
    Breast Cancer Research, 13
  • [28] Phosphatidylinositol 3-kinase/AKT signalling pathway components in human breast cancer: Clinicopathological correlations
    Gershtein, Elena S.
    Scherbakov, Alexander M.
    Shatskaya, Valentina A.
    Kushlinsky, Nicclai E.
    Krasil'Nikov, Mikhail A.
    ANTICANCER RESEARCH, 2007, 27 (4A) : 1777 - 1782
  • [29] Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
    Brana, Irene
    Siu, Lillian L.
    BMC MEDICINE, 2012, 10
  • [30] The Role of Phosphatidylinositol 3-Kinase Signaling Pathways in Pancreatic Cancer
    Sun, Chen
    Rosendahl, Ann H.
    Andersson, Roland
    Wu, DeQuan
    Wang, Xiangdong
    PANCREATOLOGY, 2011, 11 (02) : 252 - 260
12345